PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Azathioprine - Alopecia
PAD Profile : Azathioprine - Alopecia
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Baricitinib
- Hydroxychloroquine sulfate
- Doxycycline hyclate
- Minoxidil
- Ciclosporin
- Spironolactone
- Methotrexate
Other Indications
- Inflammatory bowel disease
- Hepatology Indications
- Haematology Indications
- Dermatology indications
- Rheumatology indications
- Uveitis
- Respiratory disease indications
- Renal indications
- Oral disease indications
- Neurology indications
- Scleritis
- Transplantation
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
05 February 2025
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.
See “Formulary Status” to identify where this drug has been agreed for use.
Associated BNF Codes
13. Skin
13.05.03. Drugs affecting the immune response